ArticleCancer letters2015

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.

Niranjan Awasthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.